About NorthStar Medical Radioisotopes: NorthStar Medical Radioisotopes is a pioneering company dedicated to advancing the field of nuclear medicine by producing innovative and reliable radiopharmaceuticals. As a global leader in the production and supply of critical medical radioisotopes, including molybdenum-99 (Mo-99), NorthStar is revolutionizing diagnostic imaging and therapeutic treatments for serious diseases such as cancer and heart conditions. With state-of-the-art technology and a commitment to sustainability, NorthStar provides solutions that improve patient care while reducing environmental impact. Headquartered in Beloit, Wisconsin, the company is a trusted partner in the healthcare industry, delivering cutting-edge solutions to meet the evolving needs of medicine worldwide.
Bio Highlights: Alison Hess serves as Vice President, Finance at NorthStar Medical Radioisotopes, where she brings a passion for pairing strong financial leadership with improving patient care. With extensive experience in corporate finance, Alison oversees financial reporting, budgeting, capital allocation, investor relations and risk management, ensuring the company is well positioned for sustainable growth. Alison joined NorthStar after spending 15+ years in the automotive manufacturing and distribution industries, holding various leadership positions covering finance, product management, corporate tax, operations, IT and capital management.
Alison received a Master of Business Administration degree with an Accounting emphasis from Davenport University, and a Bachelor of Business Administration degree in Finance from University of Wisconsin-Whitewater.